Patent Assignment
Reel/Frame 025463/0758
PATENT SECURITY AGREEMENT SUPPLEMENT
Recorded: 2010-12-10
Received: 2010-12-10
Pages: 12
Assignor
ACTAVIS GROUP PTC EHF.
Executed: 2010-11-23
Assignee
DEUTSCHE BANK AG, LONDON BRANCH
1 GREAT WINCHESTER STREET, WINCHESTER HOUSE, LONDON, GBX, EC2N 2DB, UNITED KINGDOM
Covered Applications
(44)
Lercanidipine Hydrochloride Polymorphs and an Improved Process for Preparation of 1,1,N-Trimethyl-N-(3,3-Diphenylpropyl)-2-Aminoethyl Acetoacetate
App. No. 12/530,101
→
STABLE ATORVASTATIN FORMULATIONS
App. No. 12/526,596
→
PROPRANOLOL FORMULATIONS
App. No. 12/476,277
→
Highly Pure Paliperidone or a Pharmaceutically Acceptable Salt Thereof Substantially Free of Keto Impurity
App. No. 12/411,526
→
SOLID FORM OF RACEMIC ROTIGOTINE
App. No. 12/369,031
→
ALENDRONATE FORMULATIONS, METHOD OF MAKING AND METHOD OF USE THEREOF
App. No. 12/365,472
→
Controlled-Release Tolterodine Compositions and Methods
App. No. 12/360,254
→
ANHYDROUS AMORPHOUS IMATINIB MESYLATE
App. No. 12/350,995
→
Pharmaceutical Formulation
App. No. 12/092,033
→
Formulations of Clopidogrel Bisulphate
App. No. 12/223,693
→
PHARMACEUTICAL FORMULATION
App. No. 12/091,877
→
PALIPERIDONE POLYMORPHS
App. No. 12/194,878
→
PROCESS FOR THE PREPARATION OF ENTACAPONE FORM-A
App. No. 12/159,667
→
PROCESS FOR PREPARING ETHYL (S)-2-ETHOXY-4-[N-[1-(2-PIPERIDINOPHENYL)-3-METHYL-1-BUTYL]AMINOCARBONYL METHYL]BENZOATE AND USE THEREOF FOR THE PREPARATION OF REPAGLINIDE
App. No. 12/031,184
→
ALENDRONATE FORMULATIONS, METHOD OF MAKING AND METHOD OF USE THEREOF
App. No. 61/026,156
→
Controlled-Release Tolterodine Compositions and Methods
App. No. 61/023,907
→
CONTROLLED-RELEASE GALANTAMINE FORMULATIONS
App. No. 11/870,444
→
Oral Dosage Formulations and Methods of Preparing the Same
App. No. 11/736,113
→
Oral Dosage Formulations, Methods of Preparing the Same, and Methods of Reducing Food Effects on Drug Release
App. No. 11/736,081
→
Oral Dosage Formulations and Methods of Preparing the Same
App. No. 11/736,048
→
VENLAFAXINE FORMULATIONS AND METHODS OF PREPARING THE SAME
App. No. 11/675,831
→
Quetiapine formulations
App. No. 11/595,758
→
Oral dosage formulations, methods of preparing the same, and methods of reducing food effects on drug release
App. No. 60/792,443
→
Oral dosage formulations and methods of preparing the same
App. No. 60/792,442
→
Paroxetine formulations
App. No. 11/199,844
→
Compressible mixture, compressed pharmaceutical compositions, and method of preparation thereof
App. No. 11/133,864
→
Amphetamine formulations
App. No. 11/078,982
→
Oral dosage formulations of active pharmaceutical ingredients and methods of preparing the same
App. No. 11/024,323
→
Atomoxetine formulations
App. No. 11/022,338
→
Rosiglitazone formulations
App. No. 11/021,491
→
Rosiglitazone and metformin formulations
App. No. 11/021,562
→
Alprazolam formulations
App. No. 11/022,037
→
Donepezil formulations
App. No. 11/022,346
→
Ziprasidone formulations
App. No. 11/022,041
→
Galantamine formulations
App. No. 11/001,712
→
Galantamine formulations
App. No. 11/001,609
→
Propranolol formulations
App. No. 10/983,202
→
Quetiapine formulations
App. No. 10/970,850
→
Atomoxetine formulations
App. No. 60/533,517
→
Galantamine formulations
App. No. 60/533,571
→
Donepezil formulations
App. No. 60/533,496
→
Alprazolam formulations
App. No. 60/533,825
→
Controlled release press-coated formulations of water-soluble active agents
App. No. 10/452,754
→
STABLE PHARMACEUTICAL FORMULATIONS OF ATORVASTATIN MAGNESIUM SALT
App. No. 12/521,621
→